-
1
المؤلفون: Nisreen Shamseddine, Namita Joshi, Xin Gao, Linlin Luo, Xingyue Huang
المصدر: Immunotherapy. 13:387-395
مصطلحات موضوعية: Adult, Male, endocrine system, medicine.medical_specialty, Immunology, Graft vs Host Disease, Disease, Medication Adherence, Time-to-Treatment, Insurance Claim Review, 03 medical and health sciences, Continuation, 0302 clinical medicine, hemic and lymphatic diseases, Internal medicine, Outcome Assessment, Health Care, Extracorporeal Photopheresis, medicine, Humans, Immunology and Allergy, Continuation rate, Retrospective Studies, business.industry, Retrospective cohort study, Imatinib, Health Care Costs, MTOR Inhibitors, Middle Aged, medicine.disease, United States, Graft-versus-host disease, Oncology, Photopheresis, 030220 oncology & carcinogenesis, Chronic Disease, Imatinib Mesylate, Health Resources, Female, business, Resource utilization, 030215 immunology, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8f3297108108dc047d6bda21297d33c3Test
https://doi.org/10.2217/imt-2020-0310Test -
2
المؤلفون: Rui Medeiros, Inês Nogueira, Francisca Dias, Mariana Morais, Ana Teixeira
المصدر: Future Oncology. 15:2361-2370
مصطلحات موضوعية: 0301 basic medicine, Cancer Research, 03 medical and health sciences, 0302 clinical medicine, Cell Line, Tumor, microRNA, Basic Helix-Loop-Helix Transcription Factors, medicine, Extracellular, Humans, Everolimus, Carcinoma, Renal Cell, business.industry, TOR Serine-Threonine Kinases, General Medicine, medicine.disease, Discovery and development of mTOR inhibitors, Kidney Neoplasms, MicroRNAs, Clear cell renal cell carcinoma, 030104 developmental biology, Oncology, Mrna level, Drug Resistance, Neoplasm, Cell culture, 030220 oncology & carcinogenesis, Cancer research, business, Intracellular, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4f6878ab9c7949ce44c509ca89591bd0Test
https://doi.org/10.2217/fon-2019-0067Test -
3
المؤلفون: Joseph Kattan, Elie El Rassy, Pamela Abdayem
المصدر: Future Oncology. 13:1451-1453
مصطلحات موضوعية: Oncology, Cancer Research, medicine.medical_specialty, Receptor, ErbB-2, Breast Neoplasms, 03 medical and health sciences, 0302 clinical medicine, Second line, Internal medicine, Humans, Medicine, Molecular Targeted Therapy, 030212 general & internal medicine, Neoplasm Metastasis, Clinical Trials as Topic, Second line treatment, biology, business.industry, Cyclin-dependent kinase 4, TOR Serine-Threonine Kinases, Estrogen Receptor alpha, Cyclin-Dependent Kinase 4, General Medicine, Discovery and development of mTOR inhibitors, medicine.disease, Metastatic breast cancer, 030220 oncology & carcinogenesis, biology.protein, Female, Signal transduction, business, Estrogen receptor alpha, Signal Transduction
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::83ed8541e954e069bf70d449deef3592Test
https://doi.org/10.2217/fon-2017-0190Test -
4
المؤلفون: Jiaqi Qian, Ping Liu, Zebo Huang, Yongqian Shu, Xin Zhou, Yinxia Wu, Wei Zhu
المصدر: Future Oncology. 11:1687-1699
مصطلحات موضوعية: Cancer Research, Docetaxel, Pharmacology, Neuroendocrine tumors, Antibodies, Monoclonal, Humanized, Erlotinib Hydrochloride, Neoplasms, Antineoplastic Combined Chemotherapy Protocols, medicine, Humans, Everolimus, Clinical efficacy, Protein Kinase Inhibitors, Sirolimus, Clinical Trials as Topic, business.industry, TOR Serine-Threonine Kinases, MTOR signaling pathway, Antibodies, Monoclonal, Gefitinib, General Medicine, medicine.disease, Discovery and development of mTOR inhibitors, Metastatic breast cancer, Minimal activity, Bevacizumab, Clinical trial, Oncology, Imatinib Mesylate, Quinazolines, Cancer research, Taxoids, Cell cancer, business, Signal Transduction
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::447947179ba225f97942fd6edc89563dTest
https://doi.org/10.2217/fon.15.70Test -
5
المصدر: Future Oncology. 11:1809-1828
مصطلحات موضوعية: Oncology, mTOR inhibitors, renal cell carcinoma, Cancer Research, medicine.medical_specialty, Antineoplastic Agents, mTORC1, Mechanistic Target of Rapamycin Complex 1, Neuroendocrine tumors, urologic and male genital diseases, medicine.disease_cause, everolimus, mTOR pathway, neuroendocrine neoplasm, temsirolimus, Animals, Carcinoma, Renal Cell, Clinical Trials as Topic, Humans, Kidney Neoplasms, Molecular Targeted Therapy, Multiprotein Complexes, Neuroendocrine Tumors, Signal Transduction, TOR Serine-Threonine Kinases, Renal cell carcinoma, Internal medicine, medicine, PI3K/AKT/mTOR pathway, Everolimus, business.industry, Carcinoma, Renal Cell, Cancer, General Medicine, medicine.disease, Temsirolimus, Carcinogenesis, business, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b67969dd2b52aa6ee442bc32e5d75ec5Test
https://doi.org/10.2217/fon.15.81Test -
6
المؤلفون: Michael Wong
المصدر: Future Neurology. 7:537-545
مصطلحات موضوعية: business.industry, Acquired epilepsy, medicine.disease, Discovery and development of mTOR inhibitors, Article, Tuberous sclerosis, Epilepsy, Clinical research, Treatment targets, Neurology, Neurotransmitter receptor, Medicine, Neurology (clinical), business, Neuroscience, PI3K/AKT/mTOR pathway
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4d73aa25b8706f654f41987ec6b39ad1Test
https://doi.org/10.2217/fnl.12.45Test -
7
المؤلفون: Piotr J Wysocki
المصدر: mTOR Inhibitors in Cancer Treatment. :20-30
مصطلحات موضوعية: Renal cell carcinoma, business.industry, medicine, Cancer research, medicine.disease, business, Discovery and development of mTOR inhibitors
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::0f765974e50290fa03e29a0ef62fbd86Test
https://doi.org/10.2217/ebo.11.172Test -
8
المؤلفون: Stéphane Oudard
المصدر: mTOR Inhibitors in Cancer Treatment. :6-18
مصطلحات موضوعية: Mechanism of action, business.industry, Cancer research, Medicine, medicine.symptom, business, Discovery and development of mTOR inhibitors
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::f51cc773a4c1a1f0e0d0d8729bdbcc3bTest
https://doi.org/10.2217/ebo.11.208Test -
9
المؤلفون: Ingrid A. Mayer
المصدر: mTOR Inhibitors in Cancer Treatment. :62-73
مصطلحات موضوعية: Breast cancer, business.industry, Cancer research, Medicine, business, medicine.disease, Discovery and development of mTOR inhibitors
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::e1f41a5b83c24637f0a441a9e11d12b8Test
https://doi.org/10.2217/ebo.11.261Test -
10
المؤلفون: Sonali M. Smith
المصدر: mTOR Inhibitors in Cancer Treatment. :74-87
مصطلحات موضوعية: Hodgkin s, business.industry, Cancer research, Medicine, Discovery and development of mTOR inhibitors, business
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::941bc823c8e1bd7958aa5505b0b4d79dTest
https://doi.org/10.2217/ebo.11.331Test